ArticleJournal of glaucoma2025
Vision-Related Quality of Life in Glaucomatous Patients With Multifocal Intraocular Lens.
Article in Journal of glaucoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PRÉCIS: Glaucoma patients with multifocal intraocular lenses (MIOLs) reported comparable vision-related quality of life but greater spectacle independence than monofocal IOL users. MIOLs may be considered for mild to moderate glaucoma patients desiring spectacle-free vision. PURPOSE: To compare the vision-related quality of life (VRQoL) in glaucomatous patients receiving bilateral monofocal intraocular lens (mIOL) and multifocal intraocular lens (MIOL) implantation. PATIENTS AND
methodsThis was a comparative, nonrandomized, unmasked, cross-sectional study in pseudophakic patients with mild to moderate glaucoma who underwent uneventful phacoemulsification with bilateral MIOL or mIOL implantation from January 2010 to June 2022 at the Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. Data collection included distant and near best corrected visual acuity (BCVA), percent of spectacle independence and VRQoL. The 25-item National Eye Institute Visual Functional Questionnaire (NEI-VFQ-25) (translated into Thai) was used to access VRQoL (score 0 to 100). The scores were adjusted for age and glaucomatous staging using the analysis of covariance (ANCOVA).
resultsA total of 109 patients were enrolled. Fifty patients received MIOL and 59 received mIOL. There was significantly more moderate glaucoma in mIOL (39.7%) the MIOL group (17.5%) ( P =0.002). Postoperatively, there was no statistically significant difference in BCVA, but the MIOL group had significantly better uncorrected near VA ( P <0.001). Spectacle-free was significantly greater in MIOL (78%) than mIOL (25.4%) ( P <0.001). Mean adjusted NEI-VFQ-25 scores was 95.4 in MIOL and 93.5 in mIOL, which was not significantly different between groups ( P =0.114).
conclusionGlaucomatous patients with multifocal IOL experienced comparable VRQoL, but more spectacle independence compared with monofocal IOL. Multifocal IOL could be considered in mild to moderate glaucomatous patients, who spectacle-free was warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.